
Ibsrela
My Prescription
Payment
Select pharmacy



$1,969.77
$30.00 due at pharmacy
$1,969.77 - $30.00 = $1,939.77
$1,939.77 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$1,969.77
Print or send this coupon to your phone
About Ibsrela
Drug Details
Tenapanor, marketed as Ibsrela, is a medication prescribed for adults suffering from irritable bowel syndrome with constipation (IBS-C). This drug functions as a sodium/hydrogen exchanger 3 (NHE3) inhibitor, effectively increasing fluid in the intestines to enhance food movement through the gut. This mechanism helps improve stool consistency and alleviate abdominal discomfort. Ibsrela is typically taken orally, twice daily. While it is generally well-tolerated, some users may experience side effects such as diarrhea, bloating, gas, and dizziness. Always consult with a healthcare professional before starting any new medication.
Price history for Ibsrela
60 Tablets, 50MG
Average retail price for Ibsrela
Average SaveHealth price for Ibsrela
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Ibsrela dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50MG | 60 Tablets | $1,969.77 | $32.83 |
Ibsrela FAQs
Ibsrela is used for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. It helps to relieve symptoms such as abdominal pain and constipation by increasing fluid secretion in the intestines and improving bowel movement regularity.
Ibsrela (tenapanor) has not been discontinued. It is still available for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. However, availability can vary, so it is advisable to check with local pharmacies or healthcare providers for the most current information.
Ibsrela (tenapanor) is not commonly associated with weight gain. Its primary use is to treat irritable bowel syndrome with constipation (IBS-C) by reducing abdominal pain and improving bowel movements. If there are concerns about weight changes while taking Ibsrela, it is advisable to consult with a healthcare provider for personalized advice.
Ibsrela (tenapanor) and Linzess (linaclotide) are both medications used to treat irritable bowel syndrome with constipation (IBS-C), but they work differently. Ibsrela is a sodium/hydrogen exchanger 3 (NHE3) inhibitor, which reduces the absorption of sodium in the intestines, leading to increased water secretion and softer stools. Linzess, on the other hand, is a guanylate cyclase-C agonist that increases the secretion of chloride and bicarbonate into the intestinal lumen, also resulting in increased fluid and softer stools. Both medications aim to relieve constipation and abdominal pain associated with IBS-C, but they have different mechanisms of action.
Ibsrela (tenapanor) should not be taken with medications that are strong inhibitors of the enzyme CYP3A4, as this can affect the metabolism of the drug. Additionally, it is important to avoid taking Ibsrela with other medications that can cause dehydration or electrolyte imbalances, as this may increase the risk of adverse effects. Patients should consult their healthcare provider for a complete list of potential drug interactions and to discuss any specific medications they are currently taking.